ROGLIANI, PAOLA
 Distribuzione geografica
Continente #
AS - Asia 1.733
NA - Nord America 909
EU - Europa 534
SA - Sud America 510
AF - Africa 115
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.810
Nazione #
US - Stati Uniti d'America 868
SG - Singapore 823
BR - Brasile 401
CN - Cina 292
HK - Hong Kong 238
VN - Vietnam 211
IT - Italia 132
IE - Irlanda 113
ZA - Sudafrica 88
NL - Olanda 70
IN - India 57
AR - Argentina 39
RU - Federazione Russa 38
SE - Svezia 31
AT - Austria 29
DE - Germania 29
MX - Messico 23
BD - Bangladesh 21
GB - Regno Unito 19
CO - Colombia 15
EC - Ecuador 15
FR - Francia 13
PY - Paraguay 13
CA - Canada 12
PL - Polonia 11
JP - Giappone 10
TR - Turchia 10
UA - Ucraina 10
ES - Italia 9
ID - Indonesia 9
MA - Marocco 9
VE - Venezuela 9
CL - Cile 8
IQ - Iraq 8
AE - Emirati Arabi Uniti 7
AU - Australia 6
CI - Costa d'Avorio 6
LT - Lituania 6
PK - Pakistan 6
EG - Egitto 5
UZ - Uzbekistan 5
CH - Svizzera 4
PE - Perù 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
BW - Botswana 3
KR - Corea 3
PT - Portogallo 3
UY - Uruguay 3
BE - Belgio 2
BO - Bolivia 2
DZ - Algeria 2
FI - Finlandia 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.810
Città #
Singapore 373
Ashburn 260
Hong Kong 236
Santa Clara 146
Dublin 113
Ho Chi Minh City 87
Beijing 84
Johannesburg 82
Dallas 68
Boardman 39
Hanoi 39
Los Angeles 37
Rome 27
São Paulo 27
New York 24
Moscow 23
Milan 20
Vienna 19
Buffalo 17
Chicago 14
Rio de Janeiro 13
Shanghai 13
Nuremberg 12
Mexico City 11
Hefei 10
Parma 10
St Louis 10
Tianjin 10
Warsaw 10
Belo Horizonte 8
Biên Hòa 8
Brooklyn 8
Columbus 8
Haiphong 8
Marseille 8
Bengaluru 7
Chandler 7
Chennai 7
Da Nang 7
Kolkata 7
Salvador 7
Abidjan 6
Curitiba 6
Denver 6
Frankfurt am Main 6
London 6
Naples 6
Redondo Beach 6
Sydney 6
Ankara 5
Brasília 5
Bắc Ninh 5
Duque de Caxias 5
Medellín 5
Porto Alegre 5
Tashkent 5
Tokyo 5
Toronto 5
Asunción 4
Bologna 4
Buenos Aires 4
Campinas 4
Casablanca 4
Dhaka 4
Fortaleza 4
Guangzhou 4
Hải Dương 4
Joinville 4
Mumbai 4
Munich 4
Ninh Bình 4
Quito 4
Ribeirão Preto 4
Seattle 4
Shenyang 4
Sumaré 4
Viamão 4
Visakhapatnam 4
Zhengzhou 4
Zurich 4
Alvorada 3
Atlanta 3
Baku 3
Barcelona 3
Blumenau 3
Bogotá 3
Cairo 3
Campos dos Goytacazes 3
Chapecó 3
Charlotte 3
Contagem 3
Gaborone 3
Genoa 3
Gières 3
Goiânia 3
Hưng Yên 3
Jinan 3
Jundiaí 3
La Plata 3
Mariano Moreno 3
Totale 2.165
Nome #
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 112
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 101
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 88
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement 87
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis 83
A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD 82
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma 73
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 71
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update 68
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 68
Challenges in treating patients with comorbid asthma and bronchiectasis 64
Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today? 64
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 63
A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem 63
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement 62
Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration 61
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review 58
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma 56
Asthma and comorbidities: recent advances 55
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol 55
Beyond Dual Bronchodilation - Triple Therapy, When and Why 54
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings 53
Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models 52
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences 52
Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene 52
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile 52
Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023 52
Bayesian or frequentist: there is no question when comparing single-inhaler triple therapies via network meta-analysis. Focus on fluticasone furoate/umeclidinium/vilanterol fixed-dose combination in chronic obstructive pulmonary disease 51
The discovery and development of gefapixant as a novel antitussive therapy 51
Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways 50
Biologics for asthma and risk of pneumonia 50
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials 50
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review 49
Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis 48
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences 47
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database 47
The Impact of Corticosteroids on Human Airway Smooth Muscle Contractility and Airway Hyperresponsiveness: A Systematic Review 46
Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies 46
Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I Error 46
Inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review and meta-analysis on mortality protection - making a long story short 45
Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on aging 45
Biologic therapies for chronic obstructive pulmonary disease 45
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD 44
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval 44
Dual bronchodilation for the treatment of COPD: From bench to bedside 43
Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition 43
An overview of the efficacy and safety of β2-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease 42
Severe Asthma and Biological Therapy: When, Which, and for Whom 42
Investigational anti IL-13 asthma treatments: a 2023 update 41
The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement 41
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application 40
The interplay between asthma and type 2 diabetes mellitus: mutual interactions and therapeutic implications 40
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases 40
Drug interaction and chronic obstructive respiratory disorders 40
Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab" 40
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways 39
Pest sensitization to cockroach, mouse, and rat: An Italian multicenter study 38
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials 38
Sex differences in adult asthma and COPD therapy: a systematic review 38
Strength of association between comorbidities and asthma: a meta-analysis 37
Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts 37
Prescribing the right therapy for the treatment of chronic cough: a critical focus on current and investigational options 36
The need for inhaled phosphodiesterase inhibitors in chronic obstructive pulmonary disease 36
Use of human airway smooth muscle in vitro and ex vivo to investigate drugs for the treatment of chronic obstructive respiratory disorders 36
Reducing the risk of death–a possible outcome in COPD patients 35
Dose of Inhaled Corticosteroids and Cardiovascular Disease in Asthma: An Unexpected Misstep? 35
Role of exosomes in exacerbations of asthma and COPD: a systematic review 35
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance 35
Systematic literature review of treatments used for refractory or unexplained chronic cough in adults 34
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/ Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis 34
PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis 33
β-Blockers and Asthma: Surprising findings from the FAERS database 33
Ensifentrine approval: A milestone in the treatment of COPD 31
Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways 30
Response 29
Novel drug discovery strategies for chronic obstructive pulmonary disease: the latest developments 29
Hyperglycaemia and Chronic Obstructive Pulmonary Disease 28
Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic Review 26
The future of inhalation therapy in chronic obstructive pulmonary disease 24
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review 22
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement 21
Totale 3.906
Categoria #
all - tutte 16.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023236 0 4 4 4 25 11 30 20 117 11 7 3
2023/2024214 16 20 17 11 14 23 26 16 21 14 8 28
2024/20251.266 13 36 137 70 105 182 55 63 181 115 81 228
2025/20262.190 352 343 510 408 490 87 0 0 0 0 0 0
Totale 3.906